0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Respiratory Infectious Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-1M4380
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Respiratory Infectious Disease Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Respiratory Infectious Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1M4380
Report
September 2024
Pages:154
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Respiratory Infectious Disease Diagnostics - Market Size

The global market for Respiratory Infectious Disease Diagnostics was estimated to be worth US$ 64120 million in 2023 and is forecast to a readjusted size of US$ 75130 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030

Respiratory Infectious Disease Diagnostics - Market

Respiratory Infectious Disease Diagnostics - Market

Respiratory Infectious Disease Diagnostics mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Infectious Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Infectious Disease Diagnostics by region & country, by Type, and by Application.
The Respiratory Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Infectious Disease Diagnostics.
Market Segmentation

Scope of Respiratory Infectious Disease Diagnostics - Market Report

Report Metric Details
Report Name Respiratory Infectious Disease Diagnostics - Market
Forecasted market size in 2030 US$ 75130 million
CAGR 2.2%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann, bioMérieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen, GENERAL ELECTRIC COMPANY, Medtronic, Novartis AG, Johnson & Johnson Services Inc, GlaxoSmithKline plc, Drägerwerk AG & Co. KGaA, GC Diagnostics Corporation, Bayer AG, Masimo, Carestream Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Respiratory Infectious Disease Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Respiratory Infectious Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Respiratory Infectious Disease Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Respiratory Infectious Disease Diagnostics - Market size in 2030?

Ans: The Respiratory Infectious Disease Diagnostics - Market size in 2030 will be US$ 75130 million.

Who are the main players in the Respiratory Infectious Disease Diagnostics - Market report?

Ans: The main players in the Respiratory Infectious Disease Diagnostics - Market are Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann, bioMérieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen, GENERAL ELECTRIC COMPANY, Medtronic, Novartis AG, Johnson & Johnson Services Inc, GlaxoSmithKline plc, Drägerwerk AG & Co. KGaA, GC Diagnostics Corporation, Bayer AG, Masimo, Carestream Health

What are the Application segmentation covered in the Respiratory Infectious Disease Diagnostics - Market report?

Ans: The Applications covered in the Respiratory Infectious Disease Diagnostics - Market report are Hospitals, Clinical Laboratories, Others

What are the Type segmentation covered in the Respiratory Infectious Disease Diagnostics - Market report?

Ans: The Types covered in the Respiratory Infectious Disease Diagnostics - Market report are Mechanical Tests, Imaging Tests, In Vitro Diagnostics (IVD) Tests

Recommended Reports

Respiratory Diagnostics

Infectious Disease

Respiratory Therapeutics

1 Market Overview
1.1 Respiratory Infectious Disease Diagnostics Product Introduction
1.2 Global Respiratory Infectious Disease Diagnostics Market Size Forecast
1.3 Respiratory Infectious Disease Diagnostics Market Trends & Drivers
1.3.1 Respiratory Infectious Disease Diagnostics Industry Trends
1.3.2 Respiratory Infectious Disease Diagnostics Market Drivers & Opportunity
1.3.3 Respiratory Infectious Disease Diagnostics Market Challenges
1.3.4 Respiratory Infectious Disease Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Respiratory Infectious Disease Diagnostics Players Revenue Ranking (2023)
2.2 Global Respiratory Infectious Disease Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Respiratory Infectious Disease Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Respiratory Infectious Disease Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Respiratory Infectious Disease Diagnostics
2.6 Respiratory Infectious Disease Diagnostics Market Competitive Analysis
2.6.1 Respiratory Infectious Disease Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Respiratory Infectious Disease Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mechanical Tests
3.1.2 Imaging Tests
3.1.3 In Vitro Diagnostics (IVD) Tests
3.2 Global Respiratory Infectious Disease Diagnostics Sales Value by Type
3.2.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinical Laboratories
4.1.3 Others
4.2 Global Respiratory Infectious Disease Diagnostics Sales Value by Application
4.2.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Region
5.1.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
5.2.2 North America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
5.3.2 Europe Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
5.5.2 South America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value
6.3 United States
6.3.1 United States Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.3.2 United States Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.4.2 Europe Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.5.2 China Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.6.2 Japan Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Respiratory Infectious Disease Diagnostics Sales Value, 2019-2030
6.9.2 India Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Respiratory Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.1.4 Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Thermo Fisher Scientific.
7.2.1 Thermo Fisher Scientific. Profile
7.2.2 Thermo Fisher Scientific. Main Business
7.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.2.4 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific. Recent Developments
7.3 Koninklijke Philips
7.3.1 Koninklijke Philips Profile
7.3.2 Koninklijke Philips Main Business
7.3.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.3.4 Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Cardinal Health Recent Developments
7.4 Cardinal Health
7.4.1 Cardinal Health Profile
7.4.2 Cardinal Health Main Business
7.4.3 Cardinal Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.4.4 Cardinal Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Cardinal Health Recent Developments
7.5 COSMED
7.5.1 COSMED Profile
7.5.2 COSMED Main Business
7.5.3 COSMED Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.5.4 COSMED Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 COSMED Recent Developments
7.6 Smiths Group
7.6.1 Smiths Group Profile
7.6.2 Smiths Group Main Business
7.6.3 Smiths Group Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.6.4 Smiths Group Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Smiths Group Recent Developments
7.7 NIHON KOHDEN CORPORATION
7.7.1 NIHON KOHDEN CORPORATION Profile
7.7.2 NIHON KOHDEN CORPORATION Main Business
7.7.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.7.4 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 NIHON KOHDEN CORPORATION Recent Developments
7.8 Becton
7.8.1 Becton Profile
7.8.2 Becton Main Business
7.8.3 Becton Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.8.4 Becton Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Becton Recent Developments
7.9 Dickinson
7.9.1 Dickinson Profile
7.9.2 Dickinson Main Business
7.9.3 Dickinson Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.9.4 Dickinson Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Dickinson Recent Developments
7.10 F.Hoffmann
7.10.1 F.Hoffmann Profile
7.10.2 F.Hoffmann Main Business
7.10.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.10.4 F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 F.Hoffmann Recent Developments
7.11 bioMérieux SA
7.11.1 bioMérieux SA Profile
7.11.2 bioMérieux SA Main Business
7.11.3 bioMérieux SA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.11.4 bioMérieux SA Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 bioMérieux SA Recent Developments
7.12 Bio-Rad Laboratories, Inc.
7.12.1 Bio-Rad Laboratories, Inc. Profile
7.12.2 Bio-Rad Laboratories, Inc. Main Business
7.12.3 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.12.4 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Bio-Rad Laboratories, Inc. Recent Developments
7.13 Quidel Corporation
7.13.1 Quidel Corporation Profile
7.13.2 Quidel Corporation Main Business
7.13.3 Quidel Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.13.4 Quidel Corporation Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Quidel Corporation Recent Developments
7.14 Siemens Healthcare GmbH
7.14.1 Siemens Healthcare GmbH Profile
7.14.2 Siemens Healthcare GmbH Main Business
7.14.3 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.14.4 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Siemens Healthcare GmbH Recent Developments
7.15 Danaher
7.15.1 Danaher Profile
7.15.2 Danaher Main Business
7.15.3 Danaher Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.15.4 Danaher Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Danaher Recent Developments
7.16 Qiagen
7.16.1 Qiagen Profile
7.16.2 Qiagen Main Business
7.16.3 Qiagen Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.16.4 Qiagen Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Qiagen Recent Developments
7.17 GENERAL ELECTRIC COMPANY
7.17.1 GENERAL ELECTRIC COMPANY Profile
7.17.2 GENERAL ELECTRIC COMPANY Main Business
7.17.3 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.17.4 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 GENERAL ELECTRIC COMPANY Recent Developments
7.18 Medtronic
7.18.1 Medtronic Profile
7.18.2 Medtronic Main Business
7.18.3 Medtronic Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.18.4 Medtronic Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.18.5 Medtronic Recent Developments
7.19 Novartis AG
7.19.1 Novartis AG Profile
7.19.2 Novartis AG Main Business
7.19.3 Novartis AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.19.4 Novartis AG Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.19.5 Novartis AG Recent Developments
7.20 Johnson & Johnson Services Inc
7.20.1 Johnson & Johnson Services Inc Profile
7.20.2 Johnson & Johnson Services Inc Main Business
7.20.3 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.20.4 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.20.5 Johnson & Johnson Services Inc Recent Developments
7.21 GlaxoSmithKline plc
7.21.1 GlaxoSmithKline plc Profile
7.21.2 GlaxoSmithKline plc Main Business
7.21.3 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.21.4 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.21.5 GlaxoSmithKline plc Recent Developments
7.22 Drägerwerk AG & Co. KGaA
7.22.1 Drägerwerk AG & Co. KGaA Profile
7.22.2 Drägerwerk AG & Co. KGaA Main Business
7.22.3 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.22.4 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.22.5 Drägerwerk AG & Co. KGaA Recent Developments
7.23 GC Diagnostics Corporation
7.23.1 GC Diagnostics Corporation Profile
7.23.2 GC Diagnostics Corporation Main Business
7.23.3 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.23.4 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.23.5 GC Diagnostics Corporation Recent Developments
7.24 Bayer AG
7.24.1 Bayer AG Profile
7.24.2 Bayer AG Main Business
7.24.3 Bayer AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.24.4 Bayer AG Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.24.5 Bayer AG Recent Developments
7.25 Masimo
7.25.1 Masimo Profile
7.25.2 Masimo Main Business
7.25.3 Masimo Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.25.4 Masimo Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.25.5 Masimo Recent Developments
7.26 Carestream Health
7.26.1 Carestream Health Profile
7.26.2 Carestream Health Main Business
7.26.3 Carestream Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
7.26.4 Carestream Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.26.5 Carestream Health Recent Developments
8 Industry Chain Analysis
8.1 Respiratory Infectious Disease Diagnostics Industrial Chain
8.2 Respiratory Infectious Disease Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Respiratory Infectious Disease Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Respiratory Infectious Disease Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Respiratory Infectious Disease Diagnostics Market Trends
    Table 2. Respiratory Infectious Disease Diagnostics Market Drivers & Opportunity
    Table 3. Respiratory Infectious Disease Diagnostics Market Challenges
    Table 4. Respiratory Infectious Disease Diagnostics Market Restraints
    Table 5. Global Respiratory Infectious Disease Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Respiratory Infectious Disease Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Respiratory Infectious Disease Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Respiratory Infectious Disease Diagnostics
    Table 10. Global Respiratory Infectious Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Respiratory Infectious Disease Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Respiratory Infectious Disease Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Respiratory Infectious Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Thermo Fisher Scientific. Basic Information List
    Table 37. Thermo Fisher Scientific. Description and Business Overview
    Table 38. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Thermo Fisher Scientific. (2019-2024)
    Table 40. Thermo Fisher Scientific. Recent Developments
    Table 41. Koninklijke Philips Basic Information List
    Table 42. Koninklijke Philips Description and Business Overview
    Table 43. Koninklijke Philips Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Koninklijke Philips (2019-2024)
    Table 45. Koninklijke Philips Recent Developments
    Table 46. Cardinal Health Basic Information List
    Table 47. Cardinal Health Description and Business Overview
    Table 48. Cardinal Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Cardinal Health (2019-2024)
    Table 50. Cardinal Health Recent Developments
    Table 51. COSMED Basic Information List
    Table 52. COSMED Description and Business Overview
    Table 53. COSMED Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of COSMED (2019-2024)
    Table 55. COSMED Recent Developments
    Table 56. Smiths Group Basic Information List
    Table 57. Smiths Group Description and Business Overview
    Table 58. Smiths Group Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Smiths Group (2019-2024)
    Table 60. Smiths Group Recent Developments
    Table 61. NIHON KOHDEN CORPORATION Basic Information List
    Table 62. NIHON KOHDEN CORPORATION Description and Business Overview
    Table 63. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of NIHON KOHDEN CORPORATION (2019-2024)
    Table 65. NIHON KOHDEN CORPORATION Recent Developments
    Table 66. Becton Basic Information List
    Table 67. Becton Description and Business Overview
    Table 68. Becton Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Becton (2019-2024)
    Table 70. Becton Recent Developments
    Table 71. Dickinson Basic Information List
    Table 72. Dickinson Description and Business Overview
    Table 73. Dickinson Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Dickinson (2019-2024)
    Table 75. Dickinson Recent Developments
    Table 76. F.Hoffmann Basic Information List
    Table 77. F.Hoffmann Description and Business Overview
    Table 78. F.Hoffmann Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of F.Hoffmann (2019-2024)
    Table 80. F.Hoffmann Recent Developments
    Table 81. bioMérieux SA Basic Information List
    Table 82. bioMérieux SA Description and Business Overview
    Table 83. bioMérieux SA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of bioMérieux SA (2019-2024)
    Table 85. bioMérieux SA Recent Developments
    Table 86. Bio-Rad Laboratories, Inc. Basic Information List
    Table 87. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 88. Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 90. Bio-Rad Laboratories, Inc. Recent Developments
    Table 91. Quidel Corporation Basic Information List
    Table 92. Quidel Corporation Description and Business Overview
    Table 93. Quidel Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Quidel Corporation (2019-2024)
    Table 95. Quidel Corporation Recent Developments
    Table 96. Siemens Healthcare GmbH Basic Information List
    Table 97. Siemens Healthcare GmbH Description and Business Overview
    Table 98. Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Siemens Healthcare GmbH (2019-2024)
    Table 100. Siemens Healthcare GmbH Recent Developments
    Table 101. Danaher Basic Information List
    Table 102. Danaher Description and Business Overview
    Table 103. Danaher Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Danaher (2019-2024)
    Table 105. Danaher Recent Developments
    Table 106. Qiagen Basic Information List
    Table 107. Qiagen Description and Business Overview
    Table 108. Qiagen Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Qiagen (2019-2024)
    Table 110. Qiagen Recent Developments
    Table 111. GENERAL ELECTRIC COMPANY Basic Information List
    Table 112. GENERAL ELECTRIC COMPANY Description and Business Overview
    Table 113. GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of GENERAL ELECTRIC COMPANY (2019-2024)
    Table 115. GENERAL ELECTRIC COMPANY Recent Developments
    Table 116. Medtronic Basic Information List
    Table 117. Medtronic Description and Business Overview
    Table 118. Medtronic Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Medtronic (2019-2024)
    Table 120. Medtronic Recent Developments
    Table 121. Novartis AG Basic Information List
    Table 122. Novartis AG Description and Business Overview
    Table 123. Novartis AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Novartis AG (2019-2024)
    Table 125. Novartis AG Recent Developments
    Table 126. Johnson & Johnson Services Inc Basic Information List
    Table 127. Johnson & Johnson Services Inc Description and Business Overview
    Table 128. Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Johnson & Johnson Services Inc (2019-2024)
    Table 130. Johnson & Johnson Services Inc Recent Developments
    Table 131. GlaxoSmithKline plc Basic Information List
    Table 132. GlaxoSmithKline plc Description and Business Overview
    Table 133. GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of GlaxoSmithKline plc (2019-2024)
    Table 135. GlaxoSmithKline plc Recent Developments
    Table 136. Drägerwerk AG & Co. KGaA Basic Information List
    Table 137. Drägerwerk AG & Co. KGaA Description and Business Overview
    Table 138. Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Drägerwerk AG & Co. KGaA (2019-2024)
    Table 140. Drägerwerk AG & Co. KGaA Recent Developments
    Table 141. GC Diagnostics Corporation Basic Information List
    Table 142. GC Diagnostics Corporation Description and Business Overview
    Table 143. GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of GC Diagnostics Corporation (2019-2024)
    Table 145. GC Diagnostics Corporation Recent Developments
    Table 146. Bayer AG Basic Information List
    Table 147. Bayer AG Description and Business Overview
    Table 148. Bayer AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Bayer AG (2019-2024)
    Table 150. Bayer AG Recent Developments
    Table 151. Masimo Basic Information List
    Table 152. Masimo Description and Business Overview
    Table 153. Masimo Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Masimo (2019-2024)
    Table 155. Masimo Recent Developments
    Table 156. Carestream Health Basic Information List
    Table 157. Carestream Health Description and Business Overview
    Table 158. Carestream Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
    Table 159. Revenue (US$ Million) in Respiratory Infectious Disease Diagnostics Business of Carestream Health (2019-2024)
    Table 160. Carestream Health Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Respiratory Infectious Disease Diagnostics Downstream Customers
    Table 164. Respiratory Infectious Disease Diagnostics Distributors List
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
    Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Respiratory Infectious Disease Diagnostics Product Picture
    Figure 2. Global Respiratory Infectious Disease Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Respiratory Infectious Disease Diagnostics Report Years Considered
    Figure 5. Global Respiratory Infectious Disease Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Infectious Disease Diagnostics Revenue in 2023
    Figure 7. Respiratory Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Mechanical Tests Picture
    Figure 9. Imaging Tests Picture
    Figure 10. In Vitro Diagnostics (IVD) Tests Picture
    Figure 11. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Clinical Laboratories
    Figure 15. Product Picture of Others
    Figure 16. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Respiratory Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Respiratory Infectious Disease Diagnostics Industrial Chain
    Figure 51. Respiratory Infectious Disease Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS